Ó³»­´«Ã½

Tests that look for hundreds of tumor mutations in blood samples could one day be used to detect residual disease in patients after treatment.

After living with angiosarcoma for decades, Jim Chapdelaine found support in an online community of patients and contributed to research that’s now shedding light on the roots of his own illness

Largest study yet of angiosarcoma reveals new mutations and suggests therapeutic possibilities for some subtypes

Pan-Cancer Project brings researchers closer to identifying all major cancer-causing genetic mutations.

Study will help narrow down the list of targets for the next generation of cancer treatments

A computational model could improve the selection of tumor antigens for personalized cancer vaccines that are now in early-stage clinical trials.

The new tool more accurately distinguishes mutations that drive cancer from ones that don’t, and could help focus future research and drug development.

A clinical study comparing liquid and tissue biopsies finds multiple resistance mechanisms in individual patients, which could explain why targeted therapies often fail.

Analyzing RNA sequencing data pinpoints ‘somatic clones,’ including some harboring cancer mutations, in many types of normal tissue.